Cargando…
DNA/RNA heteroduplex oligonucleotide technology for regulating lymphocytes in vivo
Manipulating lymphocyte functions with gene silencing approaches is promising for treating autoimmunity, inflammation, and cancer. Although oligonucleotide therapy has been proven to be successful in treating several conditions, efficient in vivo delivery of oligonucleotide to lymphocyte populations...
Autores principales: | Ohyagi, Masaki, Nagata, Tetsuya, Ihara, Kensuke, Yoshida-Tanaka, Kie, Nishi, Rieko, Miyata, Haruka, Abe, Aya, Mabuchi, Yo, Akazawa, Chihiro, Yokota, Takanori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695577/ https://www.ncbi.nlm.nih.gov/pubmed/34937876 http://dx.doi.org/10.1038/s41467-021-26902-8 |
Ejemplares similares
-
Systemic DNA/RNA heteroduplex oligonucleotide administration for regulating the gene expression of dorsal root ganglion and sciatic nerve
por: Kaburagi, Hidetoshi, et al.
Publicado: (2022) -
Highly efficient silencing of microRNA by heteroduplex oligonucleotides
por: Yoshioka, Kotaro, et al.
Publicado: (2019) -
Short DNA/RNA heteroduplex oligonucleotide interacting proteins are key regulators of target gene silencing
por: Asada, Ken, et al.
Publicado: (2021) -
Modulation of blood-brain barrier function by a heteroduplex oligonucleotide in vivo
por: Kuwahara, Hiroya, et al.
Publicado: (2018) -
DNA/RNA heteroduplex oligonucleotide for highly efficient gene silencing
por: Nishina, Kazutaka, et al.
Publicado: (2015)